“To assess the safety of tazemetostat, Epizyme conducted GLP-compliant toxicology studies of up to 13-weeks in Sprague Dawley rats and cynomolgus monkeys.”
✓ VerifiedFDA multi-discipline review, p. 32Source ↗
Pivotal GLP studies
13-week GLP oral studies in Sprague Dawley rats and cynomolgus monkeys; 13-week juvenile rat study
“Epizyme also conducted a GLP-compliant toxicology study of up to 13-weeks in juvenile Sprague Dawley rats starting from post-natal day (PND) 7 to 98.”
✓ VerifiedFDA multi-discipline review, p. 33Source ↗
Route in tox
Oral (once-daily gavage in rats; twice-daily in monkeys)
“In the 13-week monkey study, animals received oral tazemetostat at total daily doses of 100, 300, or 600 mg/kg/day (50, 150, 300 mg/kg BID).”
✓ VerifiedFDA multi-discipline review, p. 33Source ↗